Allogene Therapeutics, Inc. (ALLO)
$2.03-2.87%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $701M
- Avg volume
- 8.6M
- Beta
- 0.47
- P/E (TTM)
- -3.03
- Short % float
- 23.34%
- Days to cover
- 9.2
- SI change
- +1.7%
- 1W
- -2.40%
- 1M
- +16.67%
- 3M
- +1.50%
- YTD
- +50.37%
- vs SPY 1W
- -1.21%
- vs SPY 1M
- +13.35%
- vs SPY 3M
- -0.89%
- vs SPY YTD
- +38.62%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 3
- GROWTH
- 2
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-30.0%
REV YoY-
ROE-50.0%
EPS YoY-
ROA-30.1%
GROSS-699
OP-3886
NET-3567
[VALUATION]
P/E TTM-3.03
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.53
P/FCF-
EV/EBITDA-4.80
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E16.13
ALTMAN Z-
CURR RATIO10.72
ND/EBITDA-
BETA0.47
